High risk patients
Clinical trials for High risk patients explained in plain language.
Never miss a new study
Get alerted when new High risk patients trials appear
Sign up with your email to follow new studies for High risk patients, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to wipe out hidden colorectal cancer cells
Disease control Recruiting nowThis phase 2 trial tests two drugs, regorafenib and lorigerlimab, in people with high-risk colorectal cancer who have no visible tumors but still have cancer DNA in their blood after standard treatment. The goal is to see if the combination can clear these hidden cancer cells and…
Matched conditions: HIGH RISK PATIENTS
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can newer blood thinners beat aspirin for clot prevention in blood cancer patients?
Disease control Recruiting nowThis phase 3 trial is testing whether direct oral anticoagulants (DOACs) like apixaban or rivaroxaban are better than low-dose aspirin at preventing blood clots in people with JAK2V617F-positive myeloproliferative neoplasms (blood cancers). The study plans to enroll 1308 high-ris…
Matched conditions: HIGH RISK PATIENTS
Phase 3 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Fish oil infusion may shield heart surgery patients from dangerous rhythm disorder
Prevention Recruiting nowThis study tests whether giving fish oil through a vein during heart surgery can prevent a common complication called atrial fibrillation (irregular heartbeat) and help patients recover faster. About 550 high-risk adults having elective heart surgery will receive either fish oil …
Matched conditions: HIGH RISK PATIENTS
Phase 2 • Sponsor: GCP-Service International West GmbH • Aim: Prevention
Last updated Jul 10, 2026 00:00 UTC